Skip to main content

Find Clinical Trials

Home
Conditions
Primary Immunodeficiency Diseases

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

256 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders

NCT00005933

Conditions: Albinism, Chediak Higashi Syndrome, Chediak-Higashi Syndrome, +21 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I

NCT00001905

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +5 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Diagnostic Effectiveness of Virtual Bronchoscopy

NCT00001515

Conditions: Actinomycetales Infections, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +44 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

Gene Therapy for ADA-SCID

NCT00599781

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +8 more
Locations: Not specified

View Trial Details

Completed

Biological Significance of the Bloom's Syndrome Protein

NCT00021437

Conditions: Abnormalities, Multiple, Bloom Syndrome, Congenital Abnormalities, +8 more
Locations: New York Hospital-Cornell Medical Center New York, United States

View Trial Details

Terminated

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

NCT05047185

Conditions: Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations: Study site Birmingham, Alabama, United States

Study site Paradise Valley, Arizona, United States

Study site St Louis, Missouri, United States

Study Site Vienna, Austria

View all 19 locations

View Trial Details